Therapy Analysis & Statistics, August 2014 (p5)

Talk to Louis

+1 718 618 4302

All regions

You might be interested in: therapeutics, biotherapeutics, cancer therapeutics, more »

121-150 of about 4 600 reports

Purchase Reports From Reputable Market Research Publishers

Metabolic Deals and Alliances of 2013

Metabolic Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Metabolic Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Infectives Deals and Alliances of 2013

Infectives Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Infectives Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Genitourinary Deals and Alliances of 2013

Genitourinary Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Genitourinary Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Gastrointestinal Deals and Alliances of 2013

Gastrointestinal Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Gastrointestinal Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Dental Deals and Alliances of 2013

Dental Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Dental Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Therapy
Central Nervous System Deals and Alliances of 2013

Central Nervous System Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Central Nervous System Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
Cardiovascular Deals and Alliances of 2013

Cardiovascular Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Cardiovascular Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Therapy
 Brain Hemorrhage-Pipeline Insights, 2014

Brain Hemorrhage-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Brain Hemorrhage-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Therapy
 Chemotherapy Effects-Pipeline Insights, 2014

Chemotherapy Effects-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Chemotherapy Effects-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Therapy
 Chemotherapy Induced Anemia-Pipeline Insights, 2014

Chemotherapy Induced Anemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Chemotherapy Induced Anemia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to ...

  • Industries : Therapy
 Chemotherapy Induced Nausea and Vomiting-Pipeline Insights, 2014

Chemotherapy Induced Nausea and Vomiting-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Chemotherapy Induced Nausea and Vomiting-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the ...

  • Industries : Therapy
 Chemotherapy Induced Neutropenia-Pipeline Insights, 2014

Chemotherapy Induced Neutropenia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Chemotherapy Induced Neutropenia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report ...

  • Industries : Therapy
 Chemotherapy Induced Pain-Pipeline Insights, 2014

Chemotherapy Induced Pain-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Chemotherapy Induced Pain-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to ...

  • Industries : Therapy
 Critical Limb Ischemia-Pipeline Insights, 2014

Critical Limb Ischemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Critical Limb Ischemia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Therapy
 Dental Pain-Pipeline Insights, 2014

Dental Pain-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Dental Pain-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the ...

  • Industries : Therapy
 Diabetic Macular Edema-Pipeline Insights, 2014

Diabetic Macular Edema-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Diabetic Macular Edema-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Therapy
 Diabetic Neuropathic Pain-Pipeline Insights, 2014

Diabetic Neuropathic Pain-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Diabetic Neuropathic Pain-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to ...

  • Industries : Therapy
 Idiopathic Pulmonary Fibrosis-Pipeline Insights, 2014

Idiopathic Pulmonary Fibrosis-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Idiopathic Pulmonary Fibrosis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is ...

  • Industries : Therapy
 Ocular Inflammation-Pipeline Insights, 2014

Ocular Inflammation-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Ocular Inflammation-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Therapy
 Oral Mucositis-Pipeline Insights, 2014

Oral Mucositis-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Oral Mucositis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the ...

  • Industries : Therapy
 Peripheral Neuropathic Pain-Pipeline Insights, 2014

Peripheral Neuropathic Pain-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Peripheral Neuropathic Pain-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to ...

  • Industries : Therapy
 Post Operative Nausea And Vomiting-Pipeline Insights, 2014

Post Operative Nausea And Vomiting-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Post Operative Nausea And Vomiting-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report ...

  • Industries : Therapy
 Postherpetic Neuralgia-Pipeline Insights, 2014

Postherpetic Neuralgia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Postherpetic Neuralgia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Therapy
Aurora A Kinase Inhibitors -Pipeline Insights, 2014

Aurora A Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Aurora A Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Therapy
Aurora B Kinase Inhibitors -Pipeline Insights, 2014

Aurora B Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Aurora B Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Therapy
Aurora C Kinase Inhibitors -Pipeline Insights, 2014

Aurora C Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Aurora C Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Therapy
CaM kinase Inhibitors (Ca2+/Calmodulin-Dependent Protein Kinase Inhibitors) -Pipeline Insights, 2014

CaM kinase Inhibitors (Ca2+/Calmodulin-Dependent Protein Kinase Inhibitors) -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“CaM kinase Inhibitors (Ca2+/Calmodulin-Dependent Protein Kinase Inhibitors)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this ...

  • Industries : Therapy
Aurora Kinase Inhibitors -Pipeline Insights, 2014

Aurora Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Aurora Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Therapy
Bcr-Abl Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

Bcr-Abl Tyrosine Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Bcr-Abl Tyrosine Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Therapy
Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors -Pipeline Insights, 2014

Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Therapy

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Merck KGaA

Germany

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.